These results suggest that LPS-induced TLR-4 intracellular signals, such as ROS NFκB and MAPKs, which play an important role in transmitting inflammatory responses, could be effectively attenuated by IOE treatments in C6 glioma cells. This evidence concerns the gene TLR4 and glioma.